SIGANDA owner Contact Information online
from Glaxo Group Limited
SIGANDA
US serial number:85017403
Application filling date:Apr. 19, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned after publication because applicant filed an express abandonment. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Nov. 02, 2010
Publication date:Aug. 31, 2010
Abandoned date:Sep. 30, 2010
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabo
Current owner owner name:Glaxo Group Limited
Current owner owner address:Berkeley Avenue
Glaxo Wellcome House
Greenford, Middlesex
UNITED KINGDOM
UB60NN
Current owner legal entity type:CORPORATION
Current owner state or country:UNITED KINGDOM
Attorney name:Maribeth Day Case
Attorney email:trademarks@gsk.com
Attorney docket number:App/SIGANDA/
Attorney email authorized:Yes
Correspondent name address:Maribeth Day Case (who was appointed attorney on o
GlaxoSmithKline
LGTM, C.3157.3D
Five Moore Drive
Research Triangle Park,
NORTH CAROLINA
UNITED STATES
27709
Correspondent phone:919 483 1803
Correspondent email:trademarks@gsk.com
Correspondent fax:704 625 9190
Correspondent email authorized:Yes
Domestic representative name:Maribeth Day Case
Domestic representative phone:919 483 1803
Domestic representative fax:704 625 9190
Domestic representative email:trademarks@gsk.com
Domestic representative email authorized:Yes
Trademark staff tm attorney:MCMORROW, JANICE LEE
Trademark staff law office assigned SIGANDA:LAW OFFICE 115
Latest trademarks
Popular owners
Glaxo Group Limited (178) Novartis AG (130) JOHNSON & JOHNSON (124) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Aug. 31, 2010 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Apr. 19, 2011 Mar. 29, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
